Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Congenit Heart Dis. 2019 Jan 16;14(3):446–453. doi: 10.1111/chd.12744

Table 1:

Demographics

Subjects Entire Cohort (n=27) Neonates (n=17) Older Children (n=10) P-value
Age at repair [yr] 0.70 (0.01, 11.06) 0.05 (0.01, 2.34) 5.46 (2.54, 11.06) < .0001
Weight at repair [kg] 5.90 (3.10, 81.8) 3.82 (3.10, 13.10) 20.55 (12.4, 81.8) <.0001
Male Gender [n] 20 (74%) 12 (71%) 8 (80%) 0.6784
Cardio-Pulmonary Bypass [n] 5 (18.5%) 5 (29.4%) 0 (0%) 0.1240
Time to follow up [d] 260 (108, 544) 271 (108, 431) 252 (191, 544) 0.7756
Anti-hypertensive therapy pre-op [n] 5 (15.5%) 1 (5.9%) 4 (40.0%) 0.0473
Anti-hypertensive therapy at discharge [n] 19 (70.4%) 9 (52.9%) 10 (100%) 0.0119
Anti-hypertensive therapy at follow-up [n] 8 (33.3%) 4 (25.0%) 4 (50.0%) 0.3625
Residual outflow obstruction [n] 5 (21.7%) 4(26.7%) 1 (12.5%) 0.6214

Data presented as n (%) or median (range). P-values refer to comparison between neonatal and older children groups.